These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 34300193)

  • 1. Serum Visfatin Levels in Nonalcoholic Fatty Liver Disease and Liver Fibrosis: Systematic Review and Meta-Analysis.
    Ismaiel A; Leucuta DC; Popa SL; Dumitrascu DL
    J Clin Med; 2021 Jul; 10(14):. PubMed ID: 34300193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of Nonalcoholic Fatty Liver Disease Via a Novel Panel of Serum Adipokines.
    Jamali R; Arj A; Razavizade M; Aarabi MH
    Medicine (Baltimore); 2016 Feb; 95(5):e2630. PubMed ID: 26844476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Visceral Adiposity Index in Non-Alcoholic Fatty Liver Disease and Liver Fibrosis-Systematic Review and Meta-Analysis.
    Ismaiel A; Jaaouani A; Leucuta DC; Popa SL; Dumitrascu DL
    Biomedicines; 2021 Dec; 9(12):. PubMed ID: 34944706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasminogen Activator Inhibitor-1 Levels in Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.
    Alsharoh H; Ismaiel A; Leucuta DC; Popa SL; Dumitrascu DL
    J Gastrointestin Liver Dis; 2022 Jun; 31(2):206-214. PubMed ID: 35574617
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Lisboa QC; Nardelli MJ; Pereira PA; Miranda DM; Ribeiro SN; Costa RSN; Versiani CA; Vidigal PVT; Ferrari TCA; Couto CA
    World J Hepatol; 2020 Oct; 12(10):792-806. PubMed ID: 33200017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association Between Fibrosis Stage and Outcomes of Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.
    Taylor RS; Taylor RJ; Bayliss S; Hagström H; Nasr P; Schattenberg JM; Ishigami M; Toyoda H; Wai-Sun Wong V; Peleg N; Shlomai A; Sebastiani G; Seko Y; Bhala N; Younossi ZM; Anstee QM; McPherson S; Newsome PN
    Gastroenterology; 2020 May; 158(6):1611-1625.e12. PubMed ID: 32027911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IMPACT OF TYPE 2 DIABETES ON NONALCOHOLIC STEATOHEPATITIS AND ADVANCED FIBROSIS IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE.
    Bian H; Zhu X; Xia M; Yan H; Chang X; Hu X; Pan B; Guo W; Li X; Gao X
    Endocr Pract; 2020 Apr; 26(4):444-453. PubMed ID: 31968197
    [No Abstract]   [Full Text] [Related]  

  • 8. Liver visfatin expression in morbidly obese patients with nonalcoholic fatty liver disease undergoing bariatric surgery.
    Kukla M; Ciupińska-Kajor M; Kajor M; Wyleżoł M; Żwirska-Korczala K; Hartleb M; Berdowska A; Mazur W
    Pol J Pathol; 2010; 61(3):147-53. PubMed ID: 21225497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intestinal permeability in human nonalcoholic fatty liver disease: A systematic review and meta-analysis.
    De Munck TJI; Xu P; Verwijs HJA; Masclee AAM; Jonkers D; Verbeek J; Koek GH
    Liver Int; 2020 Dec; 40(12):2906-2916. PubMed ID: 33037768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.
    Takahashi Y; Fukusato T
    World J Gastroenterol; 2014 Nov; 20(42):15539-48. PubMed ID: 25400438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ezetimibe for the treatment of non-alcoholic fatty liver disease: A meta-analysis.
    Nakade Y; Murotani K; Inoue T; Kobayashi Y; Yamamoto T; Ishii N; Ohashi T; Ito K; Fukuzawa Y; Yoneda M
    Hepatol Res; 2017 Dec; 47(13):1417-1428. PubMed ID: 28257594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathology of nonalcoholic steatohepatitis.
    Brunt EM
    Hepatol Res; 2005 Oct; 33(2):68-71. PubMed ID: 16214395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histopathological differences utilizing the nonalcoholic fatty liver disease activity score criteria in diabetic (type 2 diabetes mellitus) and non-diabetic patients with nonalcoholic fatty liver disease.
    Puchakayala BK; Verma S; Kanwar P; Hart J; Sanivarapu RR; Mohanty SR
    World J Hepatol; 2015 Nov; 7(25):2610-8. PubMed ID: 26557954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute Coronary Syndromes and Nonalcoholic Fatty Liver Disease: "Un Affaire de Coeur".
    Ismaiel A; Popa SL; Dumitrascu DL
    Can J Gastroenterol Hepatol; 2020; 2020():8825615. PubMed ID: 33313020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum cytokeratin-18 and its relation to liver fibrosis and steatosis diagnosed by FibroScan and controlled attenuation parameter in nonalcoholic fatty liver disease and hepatitis C virus patients.
    Darweesh SK; AbdElAziz RA; Abd-ElFatah DS; AbdElazim NA; Fathi SA; Attia D; AbdAllah M
    Eur J Gastroenterol Hepatol; 2019 May; 31(5):633-641. PubMed ID: 30839434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Visceral adipose tissue visfatin in nonalcoholic fatty liver disease.
    Gaddipati R; Sasikala M; Padaki N; Mukherjee RM; Sekaran A; Jayaraj-Mansard M; Rabella P; Rao-Guduru V; Reddy-Duvvuru N
    Ann Hepatol; 2010; 9(3):266-70. PubMed ID: 20720266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Relationship between the severity of liver damage and the serum leptin level for nonalcoholic fatty liver disease].
    Kim KO; Park SH; Park CH; Han TH; Yoo KS; Kim JH; Lee MS; Kim DJ; Park CK; Cho HD
    Korean J Hepatol; 2005 Mar; 11(1):51-8. PubMed ID: 15788885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of Multiparametric US of the Liver for the Evaluation of Nonalcoholic Steatohepatitis.
    Sugimoto K; Moriyasu F; Oshiro H; Takeuchi H; Abe M; Yoshimasu Y; Kasai Y; Sakamaki K; Hara T; Itoi T
    Radiology; 2020 Sep; 296(3):532-540. PubMed ID: 32573385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noninvasive Tests Do Not Accurately Differentiate Nonalcoholic Steatohepatitis From Simple Steatosis: A Systematic Review and Meta-analysis.
    Verhaegh P; Bavalia R; Winkens B; Masclee A; Jonkers D; Koek G
    Clin Gastroenterol Hepatol; 2018 Jun; 16(6):837-861. PubMed ID: 28838784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Irisin in patients with nonalcoholic fatty liver disease.
    Polyzos SA; Kountouras J; Anastasilakis AD; Geladari EV; Mantzoros CS
    Metabolism; 2014 Feb; 63(2):207-17. PubMed ID: 24140091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.